ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 173 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2019. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $577,000 | +1.2% | 7,376 | -42.5% | 0.01% | -21.4% |
| Q1 2020 | $570,000 | -1.0% | 12,819 | -5.0% | 0.01% | +40.0% |
| Q4 2019 | $576,000 | -3.0% | 13,487 | -2.9% | 0.01% | -9.1% |
| Q3 2019 | $594,000 | -36.3% | 13,886 | -5.5% | 0.01% | -35.3% |
| Q2 2019 | $933,000 | -11.2% | 14,696 | -3.0% | 0.02% | -10.5% |
| Q1 2019 | $1,051,000 | +56.6% | 15,151 | -1.8% | 0.02% | +35.7% |
| Q4 2018 | $671,000 | -23.7% | 15,433 | +34.0% | 0.01% | 0.0% |
| Q3 2018 | $879,000 | +385.6% | 11,513 | +388.9% | 0.01% | +366.7% |
| Q2 2018 | $181,000 | – | 2,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |